Eve

Overview

Eve is the first self-balancing exoskeleton cleared for personal use, a home version of Wandercraft's clinic trainer Atalante X built for adults with spinal cord injury at any level, including tetraplegia, who cannot use the crutch-based Indego Personal or ReWalk 7. The user steers from a controller in the armrest and the twelve-motor frame handles balance, so hands stay free for daily tasks. The limits are strict, since it is for level, firm, dry indoor floors and open-air spaces attached to a building, not stairs, slopes, wet ground, public streets or crowds, it walks at under 1 km/h, weighs 83 kg at its largest setting, and a trained companion must be within arm's reach whenever it is in use. FDA 510(k) clearance K260381 was decided on 2026-08-03 and announced on August 11, and US sales began on 2026-09-17 by prescription, through National Seating & Mobility, Walk US, Good Shepherd Rehabilitation and USVetServ for VA patients, with other regions to follow. Two weeks later, on 2026-10-01, Wandercraft bought Ekso Bionics, so Eve and the Indego are now stablemates. It fits users up to 1.94 m and 100 kg.